EpiCept Corporation listed on the Nordic Exchange in Stockholm

US company EpiCept Corporation has completed the merger with Maxim Pharmaceuticals Inc and has secondary listing on Stockholm Stock Exchange’s O List as of tomorrow, January 11, 2006.

The merger of Maxim Pharmaceuticals and EpiCept was completed on January 4, 2006. Maxim had been listed on the Stockholm Stock Exchange since October 24, 1997 and the final date for trading in Maxim shares on the Stockholm Stock Exchange’s O List was December 30, 2005. Maxim shareholders received new EpiCept Corporation shares in connection with the merger. Trading in the new merged company – EpiCept Corporation – commence on the Stockholm Stock Exchange’s O List tomorrow. Trading in EpiCept shares on NASDAQ in New York started on January 5. EpiCept is a “specialty pharma” company. Following the merger with Maxim, the company has a research portfolio that includes Maxim’s cancer-treatment projects and EpiCept’s pain-relief projects. “The fact that EpiCept can now be traded on the Stockholm Stock Exchange means a lot to those investors who received EpiCept shares in exchange for their Maxim shares. At present, these investors account for approximately 28 percent of the shares in the company, of which 15 percent will be traded on the Stockholm Stock Exchange. We look forward to helping EpiCept Corporation gain maximum benefits from the Nordic financial market,” says Jenny Rosberg, President Company Services, OMX. A round lot in EpiCept Corporation, whose short name is EPCT, amounts to 200 shares and the company is included in the Healthcare and Pharmaceuticals/Biotechnology sector. For more information, please contact: Jenny Rosberg, President Company Services, OMX +46 8 405 68 81 Ulrika Olofson, Communications Manager, Stockholm Stock Exchange +46 8 405 63 76 Short facts on secondary listing on the Stockholm Stock Exchange If a company that is officially listed outside Sweden on an established and well-known exchange in the country where the company's Board of Directors is registered and where a majority of the company's shareholders reside, this company may apply for a secondary listing on Stockholm Stock Exchange. Such a company must also undergo an examination by an Exchange Auditor. This examination is less extensive than the examination conducted in a primary listing. To supplement the inquiry, Stockholm Stock Exchange will request a statement from the exchange where the company has its primary listing. About OMX OMX is a leading expert in the exchange industry. As owner and operator of the Nordic Exchange in Copenhagen, Stockholm, Helsinki, Riga, Tallinn and Vilnius, OMX offers access to approximately 80 percent of the Nordic and Baltic securities market. Our integrated technology solutions span the entire transaction chain enabling efficient securities transactions for exchanges, clearing organizations, central securities depositories and other financial institutions around the world. OMX is listed on the stock exchanges in Stockholm, Helsinki and Copenhagen. For more information please visit www.omxgroup.com.